{"transactions":[{"id":1209945,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":82068,"kind":"person","name":"Conn Morgan","position":1,"cik":"0001974124","reported_name":"Conn Morgan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finanical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-12T23:31:34.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":19500,"derivative":{"exercise_price":0.601,"expiration_date":"2035-03-11","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001062993-25-005294","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299325005294/form4.xml","form_type":"4"}},{"id":1209944,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":82068,"kind":"person","name":"Conn Morgan","position":1,"cik":"0001974124","reported_name":"Conn Morgan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finanical Officer"}}],"security":"Common Stock","published_at":"2025-03-12T23:31:34.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":79648,"source":{"system":"sec-edgar","filing":"0001062993-25-005294","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299325005294/form4.xml","form_type":"4"}},{"id":1385931,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":82068,"kind":"person","name":"Conn Morgan","position":1,"cik":"0001974124","reported_name":"Conn Morgan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finanical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-16T20:58:28.000Z","date":"2024-10-14","kind":"grant","planned":false,"acquired":true,"shares":360890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on October 14, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":360890,"derivative":{"exercise_price":1.48,"expiration_date":"2034-10-14","underlying":"Common Stock","underlying_shares":360890},"source":{"system":"sec-edgar","filing":"0001062993-24-017718","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299324017718/form4.xml","form_type":"4"}},{"id":1385930,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":82068,"kind":"person","name":"Conn Morgan","position":1,"cik":"0001974124","reported_name":"Conn Morgan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Finanical Officer"}}],"security":"Common Stock","published_at":"2024-10-16T20:58:28.000Z","date":"2024-10-14","kind":"grant","planned":false,"acquired":true,"shares":60148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the \"Company's\") common stock. The RSUs vest 25% on October 14, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock."}],"balance_after":60148,"source":{"system":"sec-edgar","filing":"0001062993-24-017718","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299324017718/form4.xml","form_type":"4"}}]}